PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+13.28%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$286M
AUM Growth
+$286M
(+89%)
Cap. Flow
+$99.4M
Cap. Flow
% of AUM
34.79%
Top 10 Holdings %
Top 10 Hldgs %
42.51%
Holding
111
New
29
Increased
24
Reduced
8
Closed
15
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$14M |
| 2 |
Dentsply Sirona
XRAY
|
$10.4M |
| 3 |
Boston Scientific
BSX
|
$7.18M |
| 4 |
VRAY
ViewRay, Inc.
VRAY
|
$6.8M |
| 5 |
Axogen
AXGN
|
$6.79M |
Top Sells
| 1 |
SI-BONE Inc
SIBN
|
$4.49M |
| 2 |
Amgen
AMGN
|
$3.89M |
| 3 |
Tandem Diabetes Care
TNDM
|
$3.61M |
| 4 |
Standard BioTools
LAB
|
$3.44M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.33M |
Sector Composition
| 1 | Healthcare | 89.3% |
| 2 | Industrials | 1.55% |
| 3 | Financials | 0.65% |
| 4 | Technology | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
SPDR S&P Biotech ETF
XBI
$5.26B
| – | – |
0
| – | – |
|
102
Health Care Select Sector SPDR Fund
XLV
$33.6B
| – | – |
0
| – | – |
|
|
NVRO
103
DELISTED
NEVRO CORP.
NVRO
| – | – |
0
| – | – |
|
|
MDRX
104
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
0
| – | – |
|
|
IMGN
105
DELISTED
Immunogen Inc
IMGN
| – | – |
0
| – | – |
|
|
CNCE
106
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – |
0
| – | – |
|
|
ABMD
107
DELISTED
Abiomed Inc
ABMD
| – | – |
0
| – | – |
|
|
GBT
108
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
0
| – | – |
|
|
RDUS
109
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-57,131
| Closed | -$942K |
|
|
ALXN
110
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-34,237
| Closed | -$3.33M |
|
|
ACET
111
DELISTED
Aceto Corp
ACET
| – | – |
-704,034
| Closed | -$591K |
|